Indication : A calcimimetic approved to manage secondary hyperparathyroidism in adults with chronic kidney disease who are on hemodialysis.
Dosage : Recommended starting dose is 5 mg by IV bolus injection three times per week at the end of hemodialysis treatment.
Leave a Reply